BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21092558)

  • 1. [VCR-loaded nanoparticles as targeted delivery system for the treatment of orbital adenoid cystic carcinoma].
    He YJ; Lin TT; Zhu LM; Luo H; Chang J; Zhang H; Zhang HM
    Zhonghua Yan Ke Za Zhi; 2010 Sep; 46(9):795-801. PubMed ID: 21092558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery.
    Zhang C; Zhao L; Dong Y; Zhang X; Lin J; Chen Z
    Eur J Pharm Biopharm; 2010 Sep; 76(1):10-6. PubMed ID: 20472060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumor effects of polybutylcyanoacrylate nanoparticles of diallyl trisulfide on orthotopic transplantation tumor model of hepatocellular carcinoma in BALB/c nude mice.
    Zhang ZM; Yang XY; Deng SH; Xu W; Gao HQ
    Chin Med J (Engl); 2007 Aug; 120(15):1336-42. PubMed ID: 17711740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An HPLC method for the pharmacokinetic study of vincristine sulfate-loaded PLGA-PEG nanoparticle formulations after injection to rats.
    Chen J; He H; Li S; Shen Q
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(21):1967-72. PubMed ID: 21665557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of colorectal cancer subcutaneous xenograft and experimental lung metastasis using nanoparticle-mediated drug delivery to tumor neovasculature.
    Wang C; Zhao M; Liu YR; Luan X; Guan YY; Lu Q; Yu DH; Bai F; Chen HZ; Fang C
    Biomaterials; 2014 Jan; 35(4):1215-26. PubMed ID: 24231414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts.
    Yoshizawa T; Hattori Y; Hakoshima M; Koga K; Maitani Y
    Eur J Pharm Biopharm; 2008 Nov; 70(3):718-25. PubMed ID: 18647651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PLGA nanoparticles simultaneously loaded with vincristine sulfate and verapamil hydrochloride: systematic study of particle size and drug entrapment efficiency.
    Song X; Zhao Y; Wu W; Bi Y; Cai Z; Chen Q; Li Y; Hou S
    Int J Pharm; 2008 Feb; 350(1-2):320-9. PubMed ID: 17913411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodistribution of indocyanine green-loaded nanoparticles with surface modifications of PEG and folic acid.
    Ma Y; Sadoqi M; Shao J
    Int J Pharm; 2012 Oct; 436(1-2):25-31. PubMed ID: 22692077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation.
    Xin H; Chen L; Gu J; Ren X; Wei Z; Luo J; Chen Y; Jiang X; Sha X; Fang X
    Int J Pharm; 2010 Dec; 402(1-2):238-47. PubMed ID: 20934500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional nanoparticles as nanocarrier for vincristine sulfate delivery to overcome tumor multidrug resistance.
    Wang Y; Dou L; He H; Zhang Y; Shen Q
    Mol Pharm; 2014 Mar; 11(3):885-94. PubMed ID: 24483832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preparation of doxorubicin encapsulated in amphiphilic polysaccharide nanoparticles and anti-hepatocarcinoma effect thereof].
    Huang YF; Gu WL; Li ZH; Chen RF; Zhou JJ; Zhou QB; Guo N
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):810-2. PubMed ID: 19595118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen.
    Slütter B; Bal S; Keijzer C; Mallants R; Hagenaars N; Que I; Kaijzel E; van Eden W; Augustijns P; Löwik C; Bouwstra J; Broere F; Jiskoot W
    Vaccine; 2010 Aug; 28(38):6282-91. PubMed ID: 20638455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid-coupled nano-paclitaxel liposome reverses drug resistance in SKOV3/TAX ovarian cancer cells.
    Tong L; Chen W; Wu J; Li H
    Anticancer Drugs; 2014 Mar; 25(3):244-54. PubMed ID: 24275314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STI571 combined with vincristine greatly suppressed the tumor formation of multidrug-resistant K562 cells in a human-nude mice xenograft model.
    Gao L; Chen L; Fei XH; Qiu HY; Zhou H; Wang JM
    Chin Med J (Engl); 2006 Jun; 119(11):911-8. PubMed ID: 16780770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment.
    Westedt U; Kalinowski M; Wittmar M; Merdan T; Unger F; Fuchs J; Schäller S; Bakowsky U; Kissel T
    J Control Release; 2007 May; 119(1):41-51. PubMed ID: 17346845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate-functionalized nanoparticles for controlled 5-Fluorouracil delivery.
    Zhang Y; Li J; Lang M; Tang X; Li L; Shen X
    J Colloid Interface Sci; 2011 Feb; 354(1):202-9. PubMed ID: 21094493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of survival in C6 rat glioma model by a sustained drug release from localized PLGA microspheres in a thermoreversible hydrogel.
    Ozeki T; Kaneko D; Hashizawa K; Imai Y; Tagami T; Okada H
    Int J Pharm; 2012 May; 427(2):299-304. PubMed ID: 22366485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zinc(II) phthalocyanine loaded PLGA nanoparticles for photodynamic therapy use.
    Ricci-Júnior E; Marchetti JM
    Int J Pharm; 2006 Mar; 310(1-2):187-95. PubMed ID: 16442755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of novel self-assembled DS-PLGA hybrid nanoparticles for improving oral bioavailability of vincristine sulfate by P-gp inhibition.
    Ling G; Zhang P; Zhang W; Sun J; Meng X; Qin Y; Deng Y; He Z
    J Control Release; 2010 Dec; 148(2):241-8. PubMed ID: 20727928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel-loaded PLGA nanoparticles: potentiation of anticancer activity by surface conjugation with wheat germ agglutinin.
    Mo Y; Lim LY
    J Control Release; 2005 Nov; 108(2-3):244-62. PubMed ID: 16213056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.